Pacer Advisors, Inc. Pacira Bio Sciences, Inc. Transaction History
Pacer Advisors, Inc.
- $40.5 Billion
- Q4 2024
A detailed history of Pacer Advisors, Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 3,262,837 shares of PCRX stock, worth $76.1 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
3,262,837
Previous 4,962,221
34.25%
Holding current value
$76.1 Million
Previous $74.7 Million
17.74%
% of portfolio
0.15%
Previous 0.18%
Shares
7 transactions
Others Institutions Holding PCRX
# of Institutions
257Shares Held
48.4MCall Options Held
429KPut Options Held
391K-
Black Rock Inc. New York, NY8.01MShares$187 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.3MShares$124 Million0.0% of portfolio
-
State Street Corp Boston, MA2.01MShares$47 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.98MShares$46.2 Million0.05% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.96MShares$45.7 Million0.03% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.07B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...